Skip to content

Effects of pregabalin combined with paracetamol and tramadol on acute pain in patients with CT-guided puncture localization of pulmonary nodules: a prospective, randomized controlled trial

Effects of pregabalin combined with paracetamol and tramadol on acute pain in patients with CT-guided puncture localization of pulmonary nodules: a prospective, randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070092
Enrollment
Unknown
Registered
2023-04-01
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT-guided puncture localization of pulmonary nodules

Interventions

Group A1B1:Two placebos were taken orally before localization
Group A1B2:Pregabalin and placebo were taken orally before localization
Group A2B1:Paracetamol and tramadol and placebo were taken orally before localization
Group A2B2:Pregabalin and paracetamol and tramadol were taken orally before localization

Sponsors

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Age of 18-65 years old; ? ASA?-?; ? Patients with pulmonary nodules who planned to undergo CT-guided puncture localization; ? Patients were informed and gave their signed consent to this study.

Exclusion criteria

Exclusion criteria: ? Patients with severe neurological or psychiatric diseases or epilepsy; ? Hypersensitivity to pregabalin and paracetamol and tramadol; ? Recent use of 5-hydroxytryptamine drugs (such as selective serotonin reuptake inhibitors and monoamine oxidase inhibitors); ? Recent regular use of other analgesics (such as opioids); ? Patients with a history of chronic chest pain before surgery; ? BMI=30kg/m2; ? Inability to communicate normally: hearing disorders, language comprehension disorders, mental diseases, etc. ? Patients with severe cardiovascular and cerebrovascular diseases and liver and kidney dysfunction before operation ? Suffering from severe respiratory diseases and obvious respiratory depression; ? Previous history of pulmonary surgery; 11 Patients who were deemed by the investigators to be ineligible to participate in the trial.

Design outcomes

Primary

MeasureTime frame
NRS score;

Secondary

MeasureTime frame
Systolic blood pressure after localization;Diastolic blood pressure after localization;Heart rate after Diastolic blood pressure after localization;Pulse oxygen saturation after localization;Incidence of moderate to severe pain;Proportion of rescue analgesia;Adverse reaction;The satisfaction of patients;

Countries

China

Contacts

Public ContactZhao Linlin

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

lin1675@163.com18168777313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026